Treatment outcome of hepatocellular carcinoma patients with high-risk vascular invasion: a retrospective analysis

1. Fan J, Zhou J, Wu Z-Q, Qiu S-J, Wang X-Y, Shi Y-H, et al. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2005; 11:1215-9.10.3748/wjg.v11.i8.1215Open DOISearch in Google Scholar

2. Nowak AK, Chow PK, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur J Cancer. 2004; 40:1474-84.10.1016/j.ejca.2004.02.027Open DOISearch in Google Scholar

3. Gotohda N, Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Furuse J, et al. New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement. World J Surg. 2006; 30:431-8.10.1007/s00268-005-0250-3Search in Google Scholar

4. Bruix J, Sala M, Llovet JM, Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004; 127:179-88.10.1053/j.gastro.2004.09.032Search in Google Scholar

5. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improved survival. Hepatology. 2003; 37:429-42.10.1053/jhep.2003.50047Search in Google Scholar

6. O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg. 2003; 90:325-31.10.1002/bjs.4045Search in Google Scholar

7. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985; 56:918-28.10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-ESearch in Google Scholar

8. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000; 31: 840-5.10.1053/he.2000.5628Search in Google Scholar

9. Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92:1862-8.10.1038/sj.bjc.6602590Search in Google Scholar

10. Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001; 233:379-84.10.1097/00000658-200103000-00012Search in Google Scholar

11. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural History of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999; 29:62-7.10.1002/hep.510290145Search in Google Scholar

12. Ohkubo T, Yamamoto J, Sugawara Y, Shimada K, Yamasaki S, Makuuchi M, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg. 2000; 191:657-60.10.1016/S1072-7515(00)00740-7Search in Google Scholar

13. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005; 137: 403-10.10.1016/j.surg.2004.12.012Search in Google Scholar

14. Ikai I, Hatano E, Hasegawa S, Fujii H, Taura K, Uyama N, et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the main portal vein. J Am Coll Surg. 2006; 202:431-8.10.1016/j.jamcollsurg.2005.11.012Search in Google Scholar

15. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362:1907-17.10.1016/S0140-6736(03)14964-1Search in Google Scholar

16. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 1992; 16:112-7.10.1002/hep.1840160119Open DOISearch in Google Scholar

17. Tzoracoleftherakis EE, Spiliotis JD, Kyriakopoulou T, Kakkos SK. Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma. Hepatogastroenterol. 1999; 46:1122-5.Search in Google Scholar

18. Yang T-S, Chang H-K, Chen J-S, Lin Y-C, Liau C-T, Chang W-C. Chemotherapy using 5-fluorouracil, mitoxantrone and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. J Gastroenterol. 2004; 39:362-9.10.1007/s00535-003-1303-8Search in Google Scholar

19. Pawlik TM, Delman KA, Vauthey J-N, Nagorney DM, Ng IO-L, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005; 11:1086-92.10.1002/lt.20472Search in Google Scholar

20. Ando E, Yamashita F, Tanaka M, Tanikawa K. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer.1997; 79:1890-6.10.1002/(SICI)1097-0142(19970515)79:10<1890::AID-CNCR8>3.0.CO;2-KSearch in Google Scholar

21. Taieb J, Bonyhay L, Golli L, Ducreux M, Boleslawski E, Tigaud JM, et al. Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules. Cancer. 2003; 98:2664-70.10.1002/cncr.11869Open DOISearch in Google Scholar

22. Lozano RD, Patt YZ, Hassan MM. Oral capectabine (Xeroda) for the treatment of hepatobiliary cancers (hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer). Proc Annu Meet Am Soc Clin Oncol. 2000; 22:A1407.Search in Google Scholar

23. Kaneko S, Urabe T, Kobayashi K. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology. 2002; 62 (Suppl 1): 69-73.10.1159/00004827911868789Search in Google Scholar

24. Ishikawa T, Ichida T, Sugitani S, Tsuboi Y, Genda T, Sugahara S, et al. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. J Gastroenterol Hepatol. 2001; 16:452-9.10.1046/j.1440-1746.2001.02352.x11354285Search in Google Scholar